Amicus Therapeutics, Inc.
US ˙ NasdaqGM ˙ US03152W1099
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityFOLD / Amicus Therapeutics, Inc.
InstitutionLegal & General Group Plc
Latest Disclosed Ownership240,554 shares
Latest Disclosed Value $ 3,478,411
Legal & General Group Plc reports 15.00% decrease in ownership of FOLD / Amicus Therapeutics, Inc.

On May 8, 2026 - Legal & General Group Plc filed a 13F-HR form disclosing ownership of 240,554 shares of Amicus Therapeutics, Inc. (US:FOLD) valued at $3,478,411 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 283,007 shares of Amicus Therapeutics, Inc.. This represents a change in shares of -15.00% during the quarter. The current value of the position is $3,485,627 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-08 2026-03-31 13F AMICUS THERAPEUTIC COM 03152W109 240,554 -42,453 -15.00 3,478 -13.70 0.0004
2026-02-09 2025-12-31 13F AMICUS THERAPEUTICS COM 03152W109 283,007 18,899 7.16 4,030 93.66 0.0009
2025-11-13 2025-09-30 13F AMICUS THERAPEUTICS COM 03152W109 264,108 -800 -0.30 2,081 37.18 0.0005
2025-08-12 2025-06-30 13F AMICUS THERAPEUTICS COM 03152W109 264,908 8,375 3.26 1,518 -27.52 0.0004
2025-05-15 2025-03-31 13F AMICUS THERAPEUTICS COM 03152W109 256,533 -531 -0.21 2,093 -13.55 0.0006
2025-02-13 2024-12-31 13F AMICUS THERAPEUTICS COM 03152W109 257,064 7,275 2.91 2,422 -9.22 0.0006
2025-02-28 2024-09-30 13F/A-2 AMICUS THERAPEUTICS COM 03152W109 249,789 22,133 9.72 2,668 18.11 0.0007
2024-11-14 2024-09-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 272,393 22,133 2,909 0.0006
2024-11-14 2024-09-30 13F AMICUS THERAPEUTICS COM 03152W109 272,393 22,133 2,909 0.0006
2025-05-29 2024-06-30 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 227,656 4,201 1.88 2,258 -14.21 0.0006
2024-08-14 2024-06-30 13F AMICUS THERAPEUTICS COM 03152W109 250,260 26,805 2,483 0.0006
2025-05-29 2024-03-31 13F/A-2 AMICUS THERAPEUTICS COM 03152W109 223,455 6,495 2.99 2,632 -14.49 0.0008
2024-07-01 2024-03-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 223,455 6,495 2,632 0.0006
2024-05-14 2024-03-31 13F AMICUS THERAPEUTICS COM 03152W109 223,455 6,495 2,632 0.0003
2025-05-29 2023-12-31 13F/A-1 AMICUS THERAPEUTICS COM 03152W109 216,960 2,719 1.27 3,079 18.16 0.0010
2024-02-15 2023-12-31 13F AMICUS THERAPEUTICS COM 03152W109 216,960 2,719 3,079 0.0008
2023-11-14 2023-09-30 13F AMICUS THERAPEUTIC COM 03152W109 214,241 4,169 1.98 2,605 -1.25 0.0009
2023-08-14 2023-06-30 13F AMICUS THERAPEUTICS COM 03152W109 210,072 -33,060 -13.60 2,639 -2.15 0.0009
2023-05-15 2023-03-31 13F AMICUS THERAPEUTIC COM 03152W109 243,132 -108,499 -30.86 2,696 -37.20 0.0010
2023-02-14 2022-12-31 13F AMICUS THERAPEUTICS COM 03152W109 351,631 31,225 9.75 4,293 28.34 0.0016
2022-11-14 2022-09-30 13F AMICUS THERAPEUTIC COM 03152W109 320,406 99,960 45.34 3,345 41.26 0.0013
2022-08-22 2022-06-30 13F AMICUS THERAPEUTICS COM 03152W109 220,446 -2,811 -1.26 2,368 12.02 0.0008
2022-05-16 2022-03-31 13F AMICUS THERAPEUTICS COM 03152W109 223,257 15,686 7.56 2,114 -11.84 0.0006
2022-02-14 2021-12-31 13F AMICUS THERAPEUTIC COM 03152W109 207,571 160 0.08 2,398 21.11 0.0007
2021-11-15 2021-09-30 13F AMICUS THERAPEUTICS COM 03152W109 207,411 41,452 24.98 1,980 23.75 0.0006
2021-08-12 2021-06-30 13F AMICUS THERAPEUTICS COM 03152W109 165,959 2,173 1.33 1,600 -1.11 0.0005
2021-05-17 2021-03-31 13F AMICUS THERAPEUTICS COM 03152W109 163,786 81 0.05 1,618 -57.20 0.0006
2021-02-12 2020-12-31 13F AMICUS THERAPEUTICS COM 03152W109 163,705 9,791 6.36 3,780 73.95 0.0015
2020-11-13 2020-09-30 13F AMICUS THERAPEUTICS COM 03152W109 153,914 -11,166 -6.76 2,173 -12.73 0.0010
2020-08-14 2020-06-30 13F AMICUS THERAPEUTICS COM 03152W109 165,080 10,684 6.92 2,490 74.49 0.0012
2020-05-14 2020-03-31 13F AMICUS THERAPEUTICS COM 03152W109 154,396 -7,398 -4.57 1,427 -9.45 0.0008
2020-02-13 2019-12-31 13F AMICUS THERAPEUTICS COM 03152W109 161,794 30,886 23.59 1,576 50.10 0.0008
2019-11-13 2019-09-30 13F AMICUS THERAPEUTICS COM 03152W109 130,908 16,166 14.09 1,050 -26.68 0.0022
2019-08-14 2019-06-30 13F AMICUS THERAPEUTICS COM 03152W109 114,742 30,909 36.87 1,432 25.61 0.0008
2019-05-15 2019-03-31 13F AMICUS THERAPEUTICS COM 03152W109 83,833 998 1.20 1,140 43.76 0.0007
2019-02-15 2018-12-31 13F AMICUS THERAPEUTICS COM 03152W109 82,835 16,234 24.38 793 -1.49 0.0006
2018-11-20 2018-09-30 13F AMICUS THERAPEUTICS COM 03152W109 66,601 0 0.00 805 -22.60 0.0006
2018-08-10 2018-06-30 13F AMICUS THERAPEUTICS COM 03152W109 66,601 -4,829 -6.76 1,040 -3.17 0.0008
2018-05-17 2018-03-31 13F AMICUS THERAPEUTICS COM 03152W109 71,430 1,479 2.11 1,074 6.34 0.0008
2018-02-13 2017-12-31 13F AMICUS THERAPEUTICS COM 03152W109 69,951 -1,334 -1.87 1,010 -5.70 0.0007
2017-11-09 2017-09-30 13F AMICUS THERAPEUTICS COM 03152W109 71,285 15,874 28.65 1,071 91.94 0.0008
2017-08-03 2017-06-30 13F AMICUS THERAPEUTICS COM 03152W109 55,411 852 1.56 558 43.08 0.0005
2017-05-12 2017-03-31 13F AMICUS THERAPEUTICS COM 03152W109 54,559 -548 -0.99 390 42.86 0.0003
2017-02-13 2016-12-31 13F AMICUS THERAPEUTICS COM 03152W109 55,107 15,396 38.77 273 -5.21 0.0003
2016-10-12 2016-09-30 13F AMICUS THERAPEUTICS COM 03152W109 39,711 9,941 33.39 288 77.78 0.0003
2016-08-16 2016-06-30 13F AMICUS THERAPEUTICS COM 03152W109 29,770 0 0.00 162 -33.61 0.0002
2016-05-16 2016-03-31 13F AMICUS THERAPEUTICS COM 03152W109 29,770 3,743 14.38 244 -2.01 0.0003
2016-02-16 2015-12-31 13F AMICUS THERAPEUTICS COM 03152W109 26,027 5,406 26.22 249 -12.01 0.0003
2015-11-13 2015-09-30 13F AMICUS THERAPEUTICS COM 03152W109 20,621 5,264 34.28 283 32.86 0.0003
2015-07-31 2015-06-30 13F AMICUS THERAPEUTICS COM 03152W109 15,357 15,357 213 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.